Megalochlamys violacea
Megalochlamys violacea · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Megalochlamys violacea is a plant species that has gained attention for its potential therapeutic applications in oral health. Research suggests that its seeds contain bioactive compounds capable of addressing various periodontal diseases. To harness these medicinal properties, scientists utilize specific preparations such as methanol extract and hot methanol extract (HME). These extracts serve as the primary medium for studying the plant's efficacy against oral pathogens and inflammation. Consequently, investigating these seed-based preparations offers a promising pathway for developing new treatments for gum-related ailments.
- Synonyms
- Monechma Violaceum · Schwabea Anisacanthus · 5 more
- Common names
- Not available
- Family
- Acanthaceae
- Distribution
- Europe
- Plant Parts
- Seed
Classification
Synonyms
Megalochlamys violacea is a botanical subject characterized by a complex history of taxonomic reclassifications. Throughout various studies, the plant has been identified under several different names, including the synonyms Dianthera violacea and Ecbolium violaceum. It has also been closely linked to the names Ecbolium anisacanthus and Justicia violacea in scientific literature. Furthermore, researchers have previously cataloged this species as Justicia anisacanthus. These shifting designations highlight the evolving nature of plant nomenclature and the intricate relationships within its genus.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Megalochlamys violacea is a unique botanical specimen belonging to the vast kingdom Plantae. Within this expansive group, it is specifically classified under the class Equisetopsida. This plant is further categorized into the order Lamiales, showcasing its specific evolutionary lineage. It also finds its place within the diverse family Acanthaceae, which defines many of its biological traits. Ultimately, this species is a distinguished member of the genus Megalochlamys.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Acanthaceae |
| Genus | Megalochlamys |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Megalochlamys violacea is a plant species with a significant presence across various regions of the African continent. It is notably distributed throughout East Tropical Africa, including specific populations found in Kenya. The species also maintains a strong foothold in Northeast Tropical Africa, spanning several distinct territories. Within this northeastern stretch, it can be identified in Djibouti, Eritrea, and Ethiopia. Furthermore, its range extends into Somalia, illustrating a wide geographical reach across these diverse landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Megalochlamys violacea is characterized by its distinct growth form as a shrub.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Megalochlamys violacea is a plant that exhibits a complex chemical profile through various isolated constituents. Research into similar medicinal profiles indicates that this species is characterized by the presence of P3, a potential small peptide. Furthermore, the plant contains coumarin, a compound often associated with diverse biological activities. Analysis also reveals that Megalochlamys violacea contains oleic acid, contributing to its unique chemical composition. These specific components highlight the significant phytochemical interest surrounding the species.
Conditions
Megalochlamys violacea, identified in the text as Monechma ciliatum, treats Porphyromonas gingivalis hemagglutinins through the inhibitory action of isolated compounds like oleic acid and coumarin. This plant treats the hemagglutination activity of P. gingivalis by hampering the vital virulence factors used by the pathogen to uptake iron. Furthermore, the plant treats hemagglutinin agents secreted by Porphyromonas gingivalis, offering a natural way to disrupt the bacteria's ability to aggregate and lyse erythrocytes. Beyond dental health, the methanol extract of the plant treats oxytocic activity, with research suggesting the presence of a small peptide principle. Ultimately, these properties allow the plant to treat periodontal diseases, serving as a potential therapeutic agent for prevention in early stages.
Preparations
Megalochlamys violacea is prepared as a hot methanol extract (HME) for specific study purposes. This plant species is also prepared as a standard methanol extract. These preparation methods allow for the isolation of various chemical principles. Both the hot methanol extract and the standard methanol extract serve as the primary forms for processing the plant. Through these specific extraction techniques, the chemical components of Megalochlamys violacea can be effectively accessed.
Parts used
Megalochlamys violacea has part seed, a characteristic shared by other botanical specimens like Monechma ciliatum. In the case of M. ciliatum, the aqueous extract derived from its seeds has demonstrated significant potential in medical research. Scientists have successfully isolated several active compounds, including oleic acid and coumarin, from these seed extracts. These specific components show high inhibitory activity against the hemagglutinin agents produced by the periodontal pathogen Porphyromonas gingivalis. Consequently, such findings suggest that these seed-derived compounds could eventually serve as effective therapeutic agents for preventing periodontal disease.